SPARQL
Downloads
Documentation/Help
Skip Header
Results
Your Query
Add common prefixes
DESCRIBE <http://purl.uniprot.org/SHA-384/F862EA895F0CFB12893419583B1937380ECFF8482615DEE881F1C2102D1077A145307346B83C6FA0C51852D618445A8E>
Submit Query
Cancel
RDF/XML
NTriples
Turtle
Show query
Share
Subject
Predicate
Object
http://purl.uniprot.org/SHA-384/F862EA895F0CFB12893419583B1937380ECFF8482615DEE881F1C2102D1077A145307346B83C6FA0C51852D618445A8E
http://www.w3.org/1999/02/22-rdf-syntax-ns#type
http://purl.uniprot.org/core/Annotation
http://purl.uniprot.org/SHA-384/F862EA895F0CFB12893419583B1937380ECFF8482615DEE881F1C2102D1077A145307346B83C6FA0C51852D618445A8E
http://www.w3.org/2000/01/rdf-schema#comment
"Data suggest that personalized peptide vaccine (PPV) with these nine CTL epitope peptides exhibit a good safety profile and positive immunological responses in HLA-A11+ or -A33+ cancer patients."
xsd:string
http://purl.uniprot.org/uniprot/#_5359C0480A5AAACF401D5DAE881B58B64D671050AD2B8A9C1918339FA6A3AE8DE6B4E5DE4AD70BEBD7C6C50BBAC38F48
http://www.w3.org/1999/02/22-rdf-syntax-ns#subject
http://purl.uniprot.org/SHA-384/F862EA895F0CFB12893419583B1937380ECFF8482615DEE881F1C2102D1077A145307346B83C6FA0C51852D618445A8E
http://purl.uniprot.org/uniprot/K4TZQ2
http://purl.uniprot.org/core/mappedAnnotation
http://purl.uniprot.org/SHA-384/F862EA895F0CFB12893419583B1937380ECFF8482615DEE881F1C2102D1077A145307346B83C6FA0C51852D618445A8E
http://purl.uniprot.org/uniprot/#_K4TZQ2-mappedCitation-28178396
http://purl.uniprot.org/core/mappedAnnotation
http://purl.uniprot.org/SHA-384/F862EA895F0CFB12893419583B1937380ECFF8482615DEE881F1C2102D1077A145307346B83C6FA0C51852D618445A8E